RC

Richard Chin

Founder of Bio Usawa

San Francisco, California

Overview 

Richard Chin is the Managing Director of Ascendant Venture and a Board Member and Co-Founder of Bio Usawa and VETmAb. He has a diverse background, holding leadership roles in various biotech and healthcare organizations while also contributing to blogs focused on clinical trials and related topics. His career highlights include founding Ambrosia BioLongevity and serving as a Clinical Associate Professor at the University of California, San Francisco.

Work Experience 

  • Managing Director

    2022 - Current

    Family office investing in early stage startups, with a preference for impact-oriented investments

  • Co-Founder and Chair of the Board

    2023

    Biotech company bringing affordable biologics to patients in Africa and other LMIC

  • Founder and Chief Executive Officer

    2021

    Biopharmaceutical company developing therapies to cure aging

  • Co-Founder and Chairman of the Board of Directors

    2022

    Developing life-changing monoclonal antibodies for pets

  • Board Member

    2021

    Nonprofit organization supporting Asian American films

Center for Asian American Media is a nonprofit organization that offers film festivals, media funding, and digital media services.

  • Co-Founder and Chairman of the Board of Directors

    2022

    Genetically improved, healthier nonallergenic pets that bring pets and pet parents closer together

  • Board Member

    2021 - 2023

    Nonprofit organization dedicated to preserving endangered languages across the planet

Wikitongues champions language diversity, downstream social justice movement safeguarding endangered languages, increasing global access.

  • Founder and Chief Executive Officer

    2012 - 2021

    Founder and CEO of KindredBio (NASDAQ:KIN), a biotech company developing drugs and biologics for pets (acquired by Elanco)

  • Clinical Associate Professor

    2010 - 2020

  • Board Member

    2011 - 2018

    Biotech company developing therapies for neurological diseases.

Balance Therapeutics is a R&D company focused on developing therapeutics to address conditions of intellectual disability.

Raised $21,183,000.00 from Pappas Ventures, Mohr Davidow Ventures and Stanford University.

Articles About Richard

Relevant Websites